Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging

被引:24
|
作者
Charil, Arnaud [1 ]
Shcherbinin, Sergey [1 ]
Southekal, Sudeepti [5 ]
Devous, Michael D. [5 ]
Mintun, Mark [1 ,5 ]
Murray, Melissa E. [4 ]
Miller, Bradley B. [1 ]
Schwarz, Adam J. [1 ,2 ,3 ]
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA
[3] Indiana Univ, Dept Radiol & Imaging Sci, Indianapolis, IN 46204 USA
[4] Mayo Clin, Jacksonville, FL 32224 USA
[5] Avid Radiopharmaceut, Philadelphia, PA USA
关键词
Hippocampal sparing; limbic predominant; subtype; tau; NEUROPATHOLOGICALLY DEFINED SUBTYPES; MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; ATROPHY; F-18-AV-1451; PATHOLOGY; RECOMMENDATIONS; PATTERNS;
D O I
10.3233/JAD-190264
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
At autopsy, individuals with Alzheimer's disease (AD) exhibit heterogeneity in the distribution of neurofibrillary tangles in neocortical and hippocampal regions. Subtypes of AD, defined using an algorithm based on the relative number of tangle counts in these regions, have been proposed-hippocampal sparing (relative sparing of the hippocampus but high cortical load), limbic predominant (high hippocampal load but lower load in association cortices), and typical (balanced neurofibrillary tangles counts in the hippocampus and association cortices) AD-and shown to be associated with distinct antemortem clinical phenotypes. The ability to distinguish these AD subtypes from the more typical tau signature in vivo could have important implications for clinical research. Flortaucipir positron emission tomography (PET) images acquired from 45 amyloid-positive participants, defined clinically as mild cognitive impairment or AD, aged 50-92 years, 56% female, and estimated to be Braak V-VI based on their PET pattern of tau pathology, were studied. By translating the neuropathologic algorithm to flortaucipir PET scans, patterns of tau pathology consistent with autopsy findings, and with a similar prevalence, were identified in vivo. 6/45 (13%) participants were identified as hippocampal sparing and 6/45 (13%) as limbic predominant AD subtypes. Hippocampal sparing participants were significantly younger than those assigned to the other two subtypes. Worse performance on delayed recall was associated with increased hippocampal tau signal, and worse performance on the trail making test B-A was associated with lower values of the hippocampus to cortex ratio. Prospective studies can further validate the flortaucipir SUVR cut-points and the phenotype of the corresponding AD subtypes.
引用
收藏
页码:1037 / 1048
页数:12
相关论文
共 50 条
  • [21] Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm
    Chiotis, Konstantinos
    Saint-Aubert, Laure
    Savitcheva, Irina
    Jelic, Vesna
    Andersen, Pia
    Jonasson, My
    Eriksson, Jonas
    Lubberink, Mark
    Almkvist, Ove
    Wall, Anders
    Antoni, Gunnar
    Nordberg, Agneta
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (09) : 1686 - 1699
  • [22] Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
    Tessa Timmers
    Rik Ossenkoppele
    Emma E. Wolters
    Sander C. J. Verfaillie
    Denise Visser
    Sandeep S. V. Golla
    Frederik Barkhof
    Philip Scheltens
    Ronald Boellaard
    Wiesje M. van der Flier
    Bart N. M. van Berckel
    Alzheimer's Research & Therapy, 11
  • [23] Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
    Chandra, Avinash
    Valkimadi, Polytimi-Eleni
    Pagano, Gennaro
    Cousins, Oliver
    Dervenoulas, George
    Politis, Marios
    HUMAN BRAIN MAPPING, 2019, 40 (18) : 5424 - 5442
  • [24] Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease
    Phillips, Jeffrey S.
    Das, Sandhitsu R.
    McMillan, Corey T.
    Irwin, David J.
    Roll, Emily E.
    Da Re, Fulvio
    Nasrallah, Ilya M.
    Wolk, David A.
    Grossman, Murray
    HUMAN BRAIN MAPPING, 2018, 39 (02) : 691 - 708
  • [25] Amyloid and Tau PET Imaging of Alzheimer Disease and Other Neurodegenerative Conditions
    Rowley, Paul A.
    Samsonov, Alexey A.
    Betthauser, Tobey J.
    Pirasteh, Ali
    Johnson, Sterling C.
    Eisenmenger, Laura B.
    SEMINARS IN ULTRASOUND CT AND MRI, 2020, 41 (06) : 572 - 583
  • [26] PET molecular imaging for pathophysiological visualization in Alzheimer's disease
    Wang, Jing
    Jin, Chentao
    Zhou, Jinyun
    Zhou, Rui
    Tian, Mei
    Lee, Hyeon Jeong
    Zhang, Hong
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (03) : 765 - 783
  • [27] PET imaging of mGluR5 in Alzheimer's disease
    Mecca, Adam P.
    McDonald, Julia W.
    Michalak, Hannah R.
    Godek, Tyler A.
    Harris, Joanna E.
    Pugh, Erika A.
    Kemp, Emily C.
    Chen, Ming-Kai
    Salardini, Arash
    Nabulsi, Nabeel B.
    Lim, Keunpoong
    Huang, Yiyun
    Carson, Richard E.
    Strittmatter, Stephen M.
    van Dyck, Christopher H.
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [28] In vivo PET imaging of neuroinflammation in Alzheimer's disease
    Lagarde, Julien
    Sarazin, Marie
    Bottlaender, Michel
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (05) : 847 - 867
  • [29] Flortaucipir PET uncovers relationships between tau and amyloid-β in primary age-related tauopathy and Alzheimer's disease
    Josephs, Keith A.
    Tosakulwong, Nirubol
    Weigand, Stephen D.
    Graff-Radford, Jonathan
    Schwarz, Christopher G.
    Senjem, Matthew L.
    Machulda, Mary M.
    Kantarci, Kejal
    Knopman, David S.
    Nguyen, Aivi
    Reichard, R. Ross
    Dickson, Dennis W.
    Petersen, Ronald C.
    Lowe, Val J.
    Jack Jr, Clifford R.
    Whitwell, Jennifer L.
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (757)
  • [30] Rates of longitudinal change in 18F-flortaucipir PET vary by brain region, cognitive impairment, and age in atypical Alzheimer's disease
    Phillips, Jeffrey S.
    Nitchie, Frederick J.
    Da Re, Fulvio
    Olm, Christopher A.
    Cook, Philip A.
    McMillan, Corey T.
    Irwin, David J.
    Gee, James C.
    Dubroff, Jacob G.
    Grossman, Murray
    Nasrallah, Ilya M.
    ALZHEIMERS & DEMENTIA, 2022, 18 (06) : 1235 - 1247